| Target Price | $266.65 |
| Price | $273.47 |
| Deviation | 2.49% |
| Number of Estimates | 48 |
| 48 Analysts have issued a price target Apple 2026 . The average Apple target price is $266.65. This is 2.49% lower than the current stock price. The highest price target is $330.75 20.95% , the lowest is $176.75 35.37% . | |
| A rating was issued by 57 analysts: 38 Analysts recommend Apple to buy, 17 to hold and 2 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Apple stock has an average upside potential 2026 of 2.49% . Most analysts recommend the Apple stock at Purchase. |
50 Analysts have issued a sales forecast Apple 2026 . The average Apple sales estimate is $457b . This is 9.89% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $490b 17.69% , the lowest is $415b 0.36% .
This results in the following potential growth metrics:
| 2025 | $416b | 6.43% |
|---|---|---|
| 2026 | $457b | 9.89% |
| 2027 | $486b | 6.36% |
| 2028 | $519b | 6.73% |
| 2029 | $558b | 7.45% |
| 2030 | $589b | 5.50% |
| 2031 | $617b | 4.83% |
34 Analysts have issued an Apple EBITDA forecast 2026. The average Apple EBITDA estimate is $155b . This is 7.24% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $175b 20.66% , the lowest is $140b 2.97% .
This results in the following potential growth metrics and future EBITDA Margins:
| 2025 | $145b | 7.49% |
|---|---|---|
| 2026 | $155b | 7.24% |
| 2027 | $167b | 7.35% |
| 2028 | $186b | 11.53% |
| 2029 | $204b | 9.76% |
| 2030 | $223b | 9.21% |
| 2031 | $238b | 6.87% |
| 2025 | 34.78% | 1.00% |
|---|---|---|
| 2026 | 33.94% | 2.42% |
| 2027 | 34.26% | 0.94% |
| 2028 | 35.80% | 4.50% |
| 2029 | 36.57% | 2.15% |
| 2030 | 37.85% | 3.50% |
| 2031 | 38.59% | 1.96% |
51 Apple Analysts have issued a net profit forecast 2026. The average Apple net profit estimate is $123b . This is 10.24% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $140b 24.64% , the lowest is $109b 2.28% .
This results in the following potential growth metrics and future Net Margins:
| 2025 | $112b | 19.50% |
|---|---|---|
| 2026 | $123b | 10.24% |
| 2027 | $136b | 10.03% |
| 2028 | $150b | 10.63% |
| 2029 | $165b | 9.45% |
| 2030 | $173b | 5.11% |
| 2031 | $249b | 44.23% |
| 2025 | 26.92% | 12.28% |
|---|---|---|
| 2026 | 27.00% | 0.32% |
| 2027 | 27.93% | 3.44% |
| 2028 | 28.95% | 3.65% |
| 2029 | 29.49% | 1.87% |
| 2030 | 29.38% | 0.37% |
| 2031 | 40.42% | 37.58% |
51 Analysts have issued a Apple forecast for earnings per share. The average Apple EPS is $8.36 . This is 11.02% higher than earnings per share in the financial year 2025. The highest EPS forecast is $9.45 25.50% , the lowest is $7.41 1.59% .
This results in the following potential growth metrics and future valuations:
| 2025 | $7.47 | 22.86% |
|---|---|---|
| 2026 | $8.36 | 11.91% |
| 2027 | $9.20 | 10.05% |
| 2028 | $10.17 | 10.54% |
| 2029 | $11.14 | 9.54% |
| 2030 | $11.70 | 5.03% |
| 2031 | $16.88 | 44.27% |
| Current | 36.32 | 1.75% |
|---|---|---|
| 2026 | 32.72 | 9.91% |
| 2027 | 29.74 | 9.11% |
| 2028 | 26.88 | 9.62% |
| 2029 | 24.56 | 8.63% |
| 2030 | 23.36 | 4.89% |
| 2031 | 16.20 | 30.65% |
Based on analysts' sales estimates for 2026, the Apple stock is valued at an EV/Sales of 8.93 and an P/S ratio of 8.84 .
This results in the following potential growth metrics and future valuations:
| Current | 9.82 | 10.59% |
|---|---|---|
| 2026 | 8.93 | 9.04% |
| 2027 | 8.40 | 5.98% |
| 2028 | 7.87 | 6.31% |
| 2029 | 7.32 | 6.93% |
| 2030 | 6.94 | 5.21% |
| 2031 | 6.62 | 4.60% |
| Current | 9.71 | 10.67% |
|---|---|---|
| 2026 | 8.84 | 9.00% |
| 2027 | 8.31 | 5.98% |
| 2028 | 7.78 | 6.31% |
| 2029 | 7.24 | 6.93% |
| 2030 | 6.87 | 5.21% |
| 2031 | 6.55 | 4.61% |
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Rosenblatt |
Neutral
➜
Neutral
|
Unchanged | Nov 04 2025 |
| Argus Research |
Buy
➜
Buy
|
Unchanged | Oct 31 2025 |
| B of A Securities |
Buy
➜
Buy
|
Unchanged | Oct 31 2025 |
| Wells Fargo |
Overweight
➜
Overweight
|
Unchanged | Oct 31 2025 |
| Barclays |
Underweight
➜
Underweight
|
Unchanged | Oct 31 2025 |
| Evercore ISI Group |
Outperform
➜
Outperform
|
Unchanged | Oct 31 2025 |
| Citigroup |
Buy
➜
Buy
|
Unchanged | Oct 31 2025 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
Rosenblatt:
Neutral
➜
Neutral
|
Nov 04 2025 |
|
Unchanged
Argus Research:
Buy
➜
Buy
|
Oct 31 2025 |
|
Unchanged
B of A Securities:
Buy
➜
Buy
|
Oct 31 2025 |
|
Unchanged
Wells Fargo:
Overweight
➜
Overweight
|
Oct 31 2025 |
|
Unchanged
Barclays:
Underweight
➜
Underweight
|
Oct 31 2025 |
|
Unchanged
Evercore ISI Group:
Outperform
➜
Outperform
|
Oct 31 2025 |
|
Unchanged
Citigroup:
Buy
➜
Buy
|
Oct 31 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


